Back to homepage

Cardiology and cardiovascular disease

Early recurrence of ischaemic stroke of cardioembolic cause and delayed anticoagulation: a case report

Authors: Agnes Aghetti, Peggy Reiner

This report describes the case of a 72-year-old man where anticoagulation therapy was postponed due to a haemorrhagic lesion, leading to new ischaemic stroke.


Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

Authors: Maurício de Almeida Ferreira, José Alexandre Mendonça

This study sought to evaluate the influence of testosterone replacement therapy in men with late-onset hypogonadism, regarding fatigue, coronary
artery disease, carotid intima-media thickness and cardiovascular risk.


Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL* protocol

Authors: Juan José Cerezo-Manchado, Olga Meca Birlanga, Luis García de Guadiana Romualdo, Ignacio Gil-Ortega, Antonio Martínez Francés, Teodoro Iturbe-Hernandez

This article discusses an update to the ANIBAL protocol in light of the COVID-19 pandemic.


New and emerging lipid-modifying drugs to lower LDL cholesterol

Authors: Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, Evangelia J Papakonstantinou, Rogers Echavarria Uceta, Eliscer Guzman

This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.


Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm

Authors: Xavier Garcia-Moll, Vivencio Barrios, Josep Franch-Nadal

This article discusses how patients with diabetes should be treated
according to their CV risk considered as a continuum and not simply as falling within primary or secondary prevention.